Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2014 under International Financial Reporting Standards (IFRS).
Key Highlights
•Consolidated revenues for FY 14 at Rs. 132.2 billion, year-on-year growth of 14%.
Help employers find you! Check out all the jobs and post your resume.
